Simony-Lafontaine J - Search Results

1

Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors.

Simony-Lafontaine J, Esslimani M, Bribes E, Gourgou S, Lequeux N, Lavail R, Grenier J, Kramar A, Casellas P. Simony-Lafontaine J, et al. Br J Cancer. 2000 Jun;82(12):1958-66. doi: 10.1054/bjoc.2000.1162. Br J Cancer. 2000. PMID: 10864204 Free PMC article.

2

p53 mutations occur in aggressive breast cancer.

Mazars R, Spinardi L, BenCheikh M, Simony-Lafontaine J, Jeanteur P, Theillet C. Mazars R, et al. Cancer Res. 1992 Jul 15;52(14):3918-23. Cancer Res. 1992. PMID: 1617667

3

Quantification of ERBB2 protein expression in breast cancer: three levels of expression defined by their clinico-pathological correlations.

Cuny M, Simony-Lafontaine J, Rouanet P, Grenier J, Valles H, Lavaill R, Louason G, Causse A, Lequeux N, Thierry C, et al. Cuny M, et al. Oncol Res. 1994;6(4-5):169-76. Oncol Res. 1994. PMID: 7841539

4

Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics.

Demoly P, Simony-Lafontaine J, Chanez P, Pujol JL, Lequeux N, Michel FB, Bousquet J. Demoly P, et al. Am J Respir Crit Care Med. 1994 Jul;150(1):214-7. doi: 10.1164/ajrccm.150.1.7912988. Am J Respir Crit Care Med. 1994. PMID: 7912988

5

Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression.

Gerber M, Astre C, Ségala C, Saintot M, Scali J, Simony-Lafontaine J, Grenier J, Pujol H. Gerber M, et al. J Nutr. 1996 Apr;126(4 Suppl):1201S-7S. doi: 10.1093/jn/126.suppl_4.1201S. J Nutr. 1996. PMID: 8642457

6

Tumor progression and oxidant-antioxidant status.

Gerber M, Astre C, Ségala C, Saintot M, Scali J, Simony-Lafontaine J, Grenier J, Pujol H. Gerber M, et al. Cancer Lett. 1997 Mar 19;114(1-2):211-4. doi: 10.1016/s0304-3835(97)04665-x. Cancer Lett. 1997. PMID: 9103294

7

[Primary angiosarcoma of the breast. Apropos of 2 cases].

Melhouf MM, Amrani N, Simony-Lafontaine J, Pujol H, Dubois JB. Melhouf MM, et al. Bull Cancer. 1997 Feb;84(2):218-22. Bull Cancer. 1997. PMID: 9180849 Review. French.

8

Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas.

Ferrières G, Cuny M, Simony-Lafontaine J, Jacquemier J, Rouleau C, Guilleux F, Grenier J, Rouanet P, Pujol H, Jeanteur P, Escot C. Ferrières G, et al. J Pathol. 1997 Oct;183(2):204-11. doi: 10.1002/(SICI)1096-9896(199710)183:2<204::AID-PATH921>3.0.CO;2-M. J Pathol. 1997. PMID: 9390034

9

Oxidant-antioxidant status in relation to survival among breast cancer patients.

Saintot M, Mathieu-Daude H, Astre C, Grenier J, Simony-Lafontaine J, Gerber M. Saintot M, et al. Int J Cancer. 2002 Feb 10;97(5):574-9. doi: 10.1002/ijc.10099. Int J Cancer. 2002. PMID: 11807780

10

Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding protein.

Vidal H, Mondesert G, Galiègue S, Carrière D, Dupuy PH, Carayon P, Combes T, Bribes E, Simony-Lafontaine J, Kramar A, Loison G, Casellas P. Vidal H, et al. Cancer Res. 2003 Aug 15;63(16):4809-18. Cancer Res. 2003. PMID: 12941800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters